Completed Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old NCT05518201 Conditions AIN1, AIN2, AIN3, +44 more Locations Center for Disease Control and Prevention — Mianzhu, Sichuan, China View Trial Details
Active, Not Recruiting A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males NCT06465914 Conditions AIN1, AIN2, AIN3, +45 more Locations Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention — Nanning, Guangxi, China Hunan Center for Disease Control and Prevention — Changsha, Hunan, China Shanxi Provincial Disease for Control and Prevention — Taiyuan, Shanxi, China Sichuan Center for Disease Control and Prevention — Chengdu, Sichuan, China View more locations Show fewer locations Loading locations... View Trial Details
